Comments
The US Food and Drug Administration has approved Gilead Sciences’ anti-viral remdesivir, making it the first treatment for Covid-19 to get the final go-ahead from the regulator. Veklury was approved for use in adult and pediatric patients aged 12 and higher, says USFDA.
Listen to the podcast.
Click here for more details.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.